Fitbit, Inc. announced on 14 September it received clearance from the US Food and Drug Administration and the CE mark in Europe for its electrocardiogram app to assess the user’s heart rhythm for atrial fibrillation (AFib) with a planned product launch in October.
The Fitbit Sense smartwatch will rival Apple Inc.'s Apple Watch and Samsung Electronics America Inc.'s Samsung Galaxy Watch...